Angiodynamics (ANGO) Depreciation and Depletion (2014 - 2015)

Angiodynamics (ANGO) reported Depreciation and Depletion of $9.4 million for Q2 2015, up 2250.0% quarter-over-quarter from $400000.0 in Q3 2014.

Angiodynamics (ANGO) Depreciation and Depletion (2014 - 2015) Analysis & Trends

Angiodynamics has reported Depreciation and Depletion for 2 years, with the latest figure at $9.4 million in Q2 2015.

For the quarter ending Q2 2015, Depreciation and Depletion changed N/A year-over-year to $9.4 million; the trailing twelve-month figure through May 2015 stood at $9.8 million (changed N/A YoY), and the FY2025 full-year result was $13.5 million, down 8.16% from the prior year.
Depreciation and Depletion for Q2 2015 stood at $9.4 million, up from $400000.0 in the prior quarter.
The five-year high for Depreciation and Depletion was $9.4 million in Q2 2015, with the low at $400000.0 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Depreciation and Depletion (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	-
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	-
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	44.60 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	38.00 Mn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	47.80 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	15.60 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	91.00 Mn
10	Angiodynamics	505.81 Mn	468.00 Mn	41.48 Mn	-

Download Data